If you need more lookups,
subscriptions start at $34 USD/month.
Paul Pearson Location
Thousand Oaks, CA, US
Paul Pearson Work
2008 -now President and CEO @
2021 -2022 Chief Development Officer (CDO) @ Lengo Therapeutics (acquired by Blueprint Medicines in Dec 2021)
2003 -2008 Vice President, Pharmacokinetics and Drug Metabolism @
1998 -2003 Executive Director, Drug Metabolism @
1990 -1998 Director, Drug Metabolism @
Paul Pearson Education
University of Washington
Post Doctoral Fellow - Medicinal Chemistry
1986-1990
Aston University
Ph.D. (Pharmaceutical Sciences)
1982-1986
Aston University
Bachelor of Science - BS (Pharmacy)
1978-1981
Paul Pearson Skills
Drug Metabolism
Pharmacokinetics
Drug Discovery
Biotechnology
Translational Medicine
Pharmaceutical Industry
Medicinal Chemistry
Drug Development
Clinical Development
Pharmacology
FDA
IND
Assay Development
CRO
Regulatory Affairs
Biopharmaceuticals
GLP
Immunology
Drug Delivery
Technology Transfer
Chromatography
Oncology
Clinical Trials
Protein Chemistry
In Vivo
Biomarkers
Lifesciences
Cell
Toxicology
HPLC
Cancer
DMPK
ADME
Biochemistry
Bioanalysis
Regulatory Submissions
In Vitro
Drug Design
Purification
Formulation
Clinical Pharmacology
Cell Culture
Senior Executive Leadership
Startup Development
Start-up Ventures
Life Sciences
Leadership
Development
Sales
Microsoft Excel
Customer Service
Business Strategy
Start Up Ventures
Paul Pearson Summary
Paul Pearson, based in Thousand Oaks, CA, US, is currently a President and CEO at PEARSON PHARMA PARTNERS. Paul Pearson brings experience from previous roles at Lengo Therapeutics (acquired by Blueprint Medicines in Dec 2021), Amgen, Merck and Pharmacia & Upjohn . Paul Pearson holds a 1986 - 1990 Post Doctoral Fellow - Medicinal Chemistry @ University of Washington. With a robust skill set that includes Drug Metabolism, Pharmacokinetics, Drug Discovery, Biotechnology, Translational Medicine and more. Paul Pearson has 2 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Paul Pearson?
Find contact details for 700 million professionals.